Soichiro Tsuda

Dr. Soichiro Tsuda

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2011 in BioSystems
Verified
Journal Article
Closed access
STSoichiro Tsuda
Soichiro Tsuda
JJJeff Jones
Jeff Jones

1 January 2009
Verified
Book Chapter
Closed access
PDF file
STSoichiro Tsuda
Soichiro Tsuda
SAStefan Artmann
Stefan Artmann
KZKlaus-Peter Zauner
Klaus-Peter Zauner

12 March 2014 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
MSMasatoshi Sakurai
Masatoshi Sakurai
TMTakehiko Mori
Takehiko Mori
JKJun Kato
Jun Kato
YKYuya Koda
Yuya Koda
TKTaku Kikuchi
Taku Kikuchi
SOShinichiro Okamoto
Shinichiro Okamoto

21 June 2024 in ACS Infectious Diseases
Verified
Journal Article
Open access
TYTakuya Yoda
Takuya Yoda
AMAyumi Matsuhashi
Ayumi Matsuhashi
AMAi Matsushita
Ai Matsushita
SSShohei Shibagaki
Shohei Shibagaki
YSYukie Sasakura
Yukie Sasakura
STSoichiro Tsuda
Soichiro Tsuda
Endolysins, peptidoglycan hydrolases derived from bacteriophages (phages), are being developed as a promising alternative to conventional antibiotics. To obtain highly active endolysins, a diverse library of these endolysins is vital. We propose here microbial single-cell genome sequencing as an efficient tool to discover dozens of previously unknown endolysins, owing to its culture-independent sequencing method. As a proof of concept, we analyzed and recovered endolysin genes within prophage regions of Staphylococcus single-amplified genomes in human skin microbiome samples. We constructed a library of chimeric endolysins by shuffling domains of the natural endolysins and performed high-throughput screening against Staphylococcus aureus. One of the lead endolysins, bbst1027, exhibited desirable antimicrobial properties, such as rapid bactericidal activity, no detectable resistance development, and in vivo efficacy. We foresee that this endolysin discovery pipeline is in principle applicable to any bacterial target and boost the development of novel antimicrobial agents.

15 May 2023 in Journal of Bioscience and Bioengineering
Verified
Journal Article
Closed access
MHMasahito Hosokawa
Masahito Hosokawa
NINaoya Iwai
Naoya Iwai
KAKoji Arikawa
Koji Arikawa
TSTatsuya Saeki
Tatsuya Saeki
TETaruho Endoh
Taruho Endoh
HTHaruko Takeyama
Haruko Takeyama

6 November 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
SRSabrina Galiñanes Reyes
Sabrina Galiñanes Reyes
YKYutetsu Kuruma
Yutetsu Kuruma
STSoichiro Tsuda
Soichiro Tsuda
Cell-free protein expression systems have been widely used for synthetic biology and metabolic engineering applications in recent years. Yet little is known about protein expression in the cell-free systems. Here we take a systems approach to uncover underlying dynamics of cell-free protein expression. We construct a set of T7 promoter variants to express proteins at different transcription rates in a reconstituted and E. coli extract-based cell-free systems. We find that the maximum expression level and the rate of protein synthesis as responses to the transcription rate change are different in the two cell-free systems, suggesting they are driven by different expression dynamics. We confirm this by constructing a simple mathematical model for each cell-free system, which well reproduce the experimental results and also identify different limiting factors for better protein expression in the two cell-free systems. In particular, they revealed there is a negative feedback effect in the mRNA-protein translation by the PURE system and also identified different limiting factors for better protein expression in the two cell-free systems.